5525-72-4 Usage
Uses
Used in Pharmaceutical Industry:
(4'-CHLORO-BIPHENYL-4-YL)-ACETIC ACID is used as a precursor in the synthesis of pharmaceutical drugs, leveraging its chemical structure to contribute to the development of new medicinal agents.
Used in Agrochemical Production:
In the agrochemical industry, (4'-CHLORO-BIPHENYL-4-YL)-ACETIC ACID serves as a starting material for the production of various agrochemicals, potentially contributing to the creation of pesticides or other agricultural chemicals.
Used in Specialty Chemicals Synthesis:
(4'-CHLORO-BIPHENYL-4-YL)-ACETIC ACID is utilized as a building block in the synthesis of specialty chemicals, where its unique structure allows for the formation of specific chemical entities for niche applications.
Used in Research and Development:
(4'-CHLORO-BIPHENYL-4-YL)-ACETIC ACID is also used in research and development settings as a key intermediate, enabling scientists to explore new chemical reactions and transformations, which could lead to innovative products and processes across multiple industries.
Check Digit Verification of cas no
The CAS Registry Mumber 5525-72-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,2 and 5 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5525-72:
(6*5)+(5*5)+(4*2)+(3*5)+(2*7)+(1*2)=94
94 % 10 = 4
So 5525-72-4 is a valid CAS Registry Number.
5525-72-4Relevant academic research and scientific papers
THIAZOLOPIPERAZINE DERIVATIVES AND COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES COMPRISING THE SAME
-
Paragraph 0118-0124; 0143; 0144, (2020/04/01)
The present invention provides a thiazolopiperazine derivative, and a pharmaceutical composition and a health functional food composition for preventing or treating autoimmune diseases containing the same as an active component. A compound represented by chemical formula 1 or a pharmaceutically acceptable salt thereof according to the present invention can have an effect of inhibiting lysophosphatidic acid 1 (LPA1) receptor activation, thereby being able to be usefully used as the pharmaceutical composition or the health functional food composition for preventing or treating LPA1-related diseases. In addition, it is possible to effectively prevent or treat not only autoimmune diseases, but also other immune-related diseases with similar mechanisms of occurrence by using the pharmaceutical composition and the health functional food composition.COPYRIGHT KIPO 2020
